Form 4 holding
Chief Business Officer
PLIANT THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 251,708
- Estimated value
- $2,767,127
- Report date
- 23 Jan 2025
- Price
- $10.99
- Ownership
- Direct
Hans Hull - Chief Business Officer at PLIANT THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Chief Business Officer
- Issuer ticker
- PLRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Hans Hull since 23 Aug 2025
Reported holdings for Hans Hull in PLIANT THERAPEUTICS, INC.
Form 4 holding
Chief Business Officer
PLIANT THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 13,985
- Estimated value
- $153,743
- Report date
- 23 Jan 2025
- Price
- $10.99
- Ownership
- Indirect
Form 4 holding
Chief Business Officer
PLIANT THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 80,300
- Estimated value
- Report date
- 23 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Hans Hull in PLIANT THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.